The Food and Drug Administration's new guidance should create a clear path for generic makers of insulin to enter the market. But some say it will do little to reverse its rising cost.
The Supreme Court avoided a high-profile case by rejecting appeals from Kansas and Louisiana in their effort to strip Medicaid money from Planned Parenthood, over the dissenting votes of three justices.
A House panel will question ONC leaders about progress the agency is making on implementing the 21st Century Cures Act.
The CMS issued a final rule that allows the agency to continue the normal operations of the Affordable Care Act risk-adjustment program for 2018.
Idaho's highest court will hear arguments in January in a lawsuit seeking to block the state's voter-approved Medicaid expansion.
Two major hospital groups and three health systems sued the Trump administration over the site-neutral payment policy due to go into effect Jan. 1.
Of the 148 applications the GAO analyzed, reviewers granted orphan status to 26 that were missing required information.
A federal judge told pharmacy giant CVS Health and the insurer Aetna that they have to keep their management separate until he weighs in on their $70 billion merger.
The congressional session is winding down, but there's no shortage of hearings. Key committees will look at how the VA is implementing the Mission Act. Also, federal antitrust regulators will detail their approaches to hospital consolidation.
HHS finally will allow a ceiling price rule for the 340B program to kick in after years of delays. The price cap will go into effect on Jan. 1.
The CMS has issued four new examples on how states can use 1332 waivers to customize health insurance offerings. But a former agency official warns that using any of the new flexibilities could result in litigation.
Virginia has submitted its proposed work requirement plan for some Medicaid recipients to the federal government for approval.